1 | curative | 1,995 |
2 | additive | 1,848 |
3 | suppressive | 537 |
4 | r0 | 228 |
5 | life-saving | 207 |
6 | mesorectal | 200 |
7 | electrosurgical | 198 |
8 | ergogenic | 166 |
9 | bystander | 140 |
10 | bloc | 101 |
11 | abdominoperineal | 73 |
12 | ileocolonic | 26 |
13 | old/new | 24 |
14 | piecemeal | 23 |
15 | medium-to-large | 21 |
16 | immunoprotective | 20 |
17 | quadrangular | 19 |
18 | moderate-to-large | 18 |
19 | down-staging | 13 |
20 | gonadotoxic | 13 |
21 | noncurative | 13 |
22 | gross-total | 10 |
23 | antiremodeling | 9 |
24 | first-ray | 9 |
25 | hourglass | 9 |
26 | interrogative | 9 |
27 | medium-large | 9 |
28 | anti-feeding | 8 |
29 | trapezial | 8 |
30 | mesocolic | 7 |
31 | nonanesthetic | 7 |
32 | trait-specific | 7 |
33 | 'curative | 6 |
34 | antirefluxing | 6 |
35 | graft-versus-tumor | 6 |
36 | immune-suppressive | 6 |
37 | immunomodulative | 6 |
38 | leukemogenic | 6 |
39 | biopreservative | 5 |
40 | empirically-based | 5 |
41 | hdc/il-2 | 5 |
42 | non-hematopoietic | 5 |
43 | r0/r1 | 5 |
44 | whole-gland | 5 |
45 | a-2b/rbv | 4 |
46 | astigmatism-reducing | 4 |
47 | cvrp | 4 |
48 | knock-on | 4 |
49 | quadrangle | 4 |
50 | uncertain/negative | 4 |
51 | antiwrinkle | 3 |
52 | discohesive | 3 |
53 | evidence-guided | 3 |
54 | fm-to-am | 3 |
55 | multitudinous | 3 |
56 | photoinhibitory | 3 |
57 | placebo-plus-interaction | 3 |
58 | same-session | 3 |
59 | transuretheral | 3 |
60 | 29,697 | 2 |
61 | acl-remnant | 2 |
62 | alprazolam/zolpidem | 2 |
63 | anti-cinv | 2 |
64 | antiaggression | 2 |
65 | ar-dependent | 2 |
66 | atropine-sensitive | 2 |
67 | concentrate-sparing | 2 |
68 | contour-loop | 2 |
69 | de-copper | 2 |
70 | eradicative | 2 |
71 | estrogen-agonistic | 2 |
72 | firstcyte | 2 |
73 | h01-emergency | 2 |
74 | ics-sparing | 2 |
75 | ischemia-reperfusion-like | 2 |
76 | kirkendall | 2 |
77 | marsupialization/partial | 2 |
78 | mineralizable | 2 |
79 | post-mus | 2 |
80 | post-r0 | 2 |
81 | post-transurethral | 2 |
82 | primary-site | 2 |
83 | r1/2 | 2 |
84 | 'blue-light'-assisted | 1 |
85 | 'circumferential | 1 |
86 | 'electron | 1 |
87 | 'id-verify | 1 |
88 | 2013.anticonvulsant | 1 |
89 | 37.191 | 1 |
90 | 5,436 | 1 |
91 | 70,154 | 1 |
92 | a-2a | 1 |
93 | acupoint-specific | 1 |
94 | agency/european | 1 |
95 | alarge | 1 |
96 | aldosterone-like | 1 |
97 | alleviative | 1 |
98 | anthracycline-cytarabine | 1 |
99 | anti-all | 1 |
100 | anti-anginous | 1 |
101 | anti-bc | 1 |
102 | anti-fibrogenetic | 1 |
103 | anti-metabolic | 1 |
104 | anti-parkinsonion | 1 |
105 | anti-tumorigenesis | 1 |
106 | antiadrenergic/vagomimetic | 1 |
107 | anticirrhotic | 1 |
108 | anticonflict | 1 |
109 | antileukopenic | 1 |
110 | antiluteolytic | 1 |
111 | antinocicepitve | 1 |
112 | antiperoxidation | 1 |
113 | antireflection | 1 |
114 | apicectomy/root-end | 1 |
115 | aromatase-inhibiting | 1 |
116 | arythmogenic | 1 |
117 | ayahuasca-assisted | 1 |
118 | azt-monophosphate | 1 |
119 | belly-strip | 1 |
120 | biopsy/hysteroscopic | 1 |
121 | c-lowering | 1 |
122 | cell-reducing | 1 |
123 | chemoacoustic | 1 |
124 | crm/r0 | 1 |
125 | discontinua | 1 |
126 | dual-shape | 1 |
127 | embolization-assisted | 1 |
128 | erα+ | 1 |
129 | estrogen-antagonistic | 1 |
130 | estrogenic/anti-estrogen | 1 |
131 | etoricoxib-related | 1 |
132 | event-lowering | 1 |
133 | extra-beneficial | 1 |
134 | gibbs-like | 1 |
135 | graft-vs-leukaemia | 1 |
136 | group-by-week | 1 |
137 | hangar | 1 |
138 | high/poor | 1 |
139 | human-function | 1 |
140 | inflammation-attenuating | 1 |
141 | inmuno-supressor | 1 |
142 | intestine-conditioning | 1 |
143 | ionophoric | 1 |
144 | ivf-preimplantation | 1 |
145 | kuntz | 1 |
146 | low-anterior | 1 |
147 | magnetic-memory | 1 |
148 | mcp-1-lowering | 1 |
149 | medio-posterior | 1 |
150 | metabolism/signaling | 1 |
151 | mi-protective | 1 |
152 | mini-fluorescence-assisted | 1 |
153 | moderate-to-small | 1 |
154 | modo | 1 |
155 | myo-relaxant | 1 |
156 | non-transthoracic | 1 |
157 | nonsecond | 1 |
158 | obesity-reducing | 1 |
159 | osteopenia-an | 1 |
160 | outcome-limiting | 1 |
161 | p-treatment | 1 |
162 | perfusion+local | 1 |
163 | pleothropic | 1 |
164 | post-oida | 1 |
165 | pre-oida | 1 |
166 | proof-of-target | 1 |
167 | prostate/transurethral | 1 |
168 | r-0 | 1 |
169 | r0/marginal | 1 |
170 | random-model | 1 |
171 | rt-dose | 1 |
172 | sanitat | 1 |
173 | sub-perichondrial | 1 |
174 | suicidal/homicidal | 1 |
175 | supra-auricular | 1 |
176 | thransthoracic | 1 |
177 | thrombolysable | 1 |
178 | time-of-sample | 1 |
179 | trans-cervical | 1 |
180 | upregulatory | 1 |
181 | wedge/tumor | 1 |
182 | whole-tumor | 1 |
1 | 'blue-light'-assisted | 1 |
2 | 'circumferential | 1 |
3 | 'curative | 6 |
4 | 'electron | 1 |
5 | 'id-verify | 1 |
6 | 2013.anticonvulsant | 1 |
7 | 29,697 | 2 |
8 | 37.191 | 1 |
9 | 5,436 | 1 |
10 | 70,154 | 1 |
11 | a-2a | 1 |
12 | a-2b/rbv | 4 |
13 | abdominoperineal | 73 |
14 | acl-remnant | 2 |
15 | acupoint-specific | 1 |
16 | additive | 1,848 |
17 | agency/european | 1 |
18 | alarge | 1 |
19 | aldosterone-like | 1 |
20 | alleviative | 1 |
21 | alprazolam/zolpidem | 2 |
22 | anthracycline-cytarabine | 1 |
23 | anti-all | 1 |
24 | anti-anginous | 1 |
25 | anti-bc | 1 |
26 | anti-cinv | 2 |
27 | anti-feeding | 8 |
28 | anti-fibrogenetic | 1 |
29 | anti-metabolic | 1 |
30 | anti-parkinsonion | 1 |
31 | anti-tumorigenesis | 1 |
32 | antiadrenergic/vagomimetic | 1 |
33 | antiaggression | 2 |
34 | anticirrhotic | 1 |
35 | anticonflict | 1 |
36 | antileukopenic | 1 |
37 | antiluteolytic | 1 |
38 | antinocicepitve | 1 |
39 | antiperoxidation | 1 |
40 | antireflection | 1 |
41 | antirefluxing | 6 |
42 | antiremodeling | 9 |
43 | antiwrinkle | 3 |
44 | apicectomy/root-end | 1 |
45 | ar-dependent | 2 |
46 | aromatase-inhibiting | 1 |
47 | arythmogenic | 1 |
48 | astigmatism-reducing | 4 |
49 | atropine-sensitive | 2 |
50 | ayahuasca-assisted | 1 |
51 | azt-monophosphate | 1 |
52 | belly-strip | 1 |
53 | biopreservative | 5 |
54 | biopsy/hysteroscopic | 1 |
55 | bloc | 101 |
56 | bystander | 140 |
57 | c-lowering | 1 |
58 | cell-reducing | 1 |
59 | chemoacoustic | 1 |
60 | concentrate-sparing | 2 |
61 | contour-loop | 2 |
62 | crm/r0 | 1 |
63 | curative | 1,995 |
64 | cvrp | 4 |
65 | de-copper | 2 |
66 | discohesive | 3 |
67 | discontinua | 1 |
68 | down-staging | 13 |
69 | dual-shape | 1 |
70 | electrosurgical | 198 |
71 | embolization-assisted | 1 |
72 | empirically-based | 5 |
73 | eradicative | 2 |
74 | ergogenic | 166 |
75 | erα+ | 1 |
76 | estrogen-agonistic | 2 |
77 | estrogen-antagonistic | 1 |
78 | estrogenic/anti-estrogen | 1 |
79 | etoricoxib-related | 1 |
80 | event-lowering | 1 |
81 | evidence-guided | 3 |
82 | extra-beneficial | 1 |
83 | first-ray | 9 |
84 | firstcyte | 2 |
85 | fm-to-am | 3 |
86 | gibbs-like | 1 |
87 | gonadotoxic | 13 |
88 | graft-versus-tumor | 6 |
89 | graft-vs-leukaemia | 1 |
90 | gross-total | 10 |
91 | group-by-week | 1 |
92 | h01-emergency | 2 |
93 | hangar | 1 |
94 | hdc/il-2 | 5 |
95 | high/poor | 1 |
96 | hourglass | 9 |
97 | human-function | 1 |
98 | ics-sparing | 2 |
99 | ileocolonic | 26 |
100 | immune-suppressive | 6 |
101 | immunomodulative | 6 |
102 | immunoprotective | 20 |
103 | inflammation-attenuating | 1 |
104 | inmuno-supressor | 1 |
105 | interrogative | 9 |
106 | intestine-conditioning | 1 |
107 | ionophoric | 1 |
108 | ischemia-reperfusion-like | 2 |
109 | ivf-preimplantation | 1 |
110 | kirkendall | 2 |
111 | knock-on | 4 |
112 | kuntz | 1 |
113 | leukemogenic | 6 |
114 | life-saving | 207 |
115 | low-anterior | 1 |
116 | magnetic-memory | 1 |
117 | marsupialization/partial | 2 |
118 | mcp-1-lowering | 1 |
119 | medio-posterior | 1 |
120 | medium-large | 9 |
121 | medium-to-large | 21 |
122 | mesocolic | 7 |
123 | mesorectal | 200 |
124 | metabolism/signaling | 1 |
125 | mi-protective | 1 |
126 | mineralizable | 2 |
127 | mini-fluorescence-assisted | 1 |
128 | moderate-to-large | 18 |
129 | moderate-to-small | 1 |
130 | modo | 1 |
131 | multitudinous | 3 |
132 | myo-relaxant | 1 |
133 | non-hematopoietic | 5 |
134 | non-transthoracic | 1 |
135 | nonanesthetic | 7 |
136 | noncurative | 13 |
137 | nonsecond | 1 |
138 | obesity-reducing | 1 |
139 | old/new | 24 |
140 | osteopenia-an | 1 |
141 | outcome-limiting | 1 |
142 | p-treatment | 1 |
143 | perfusion+local | 1 |
144 | photoinhibitory | 3 |
145 | piecemeal | 23 |
146 | placebo-plus-interaction | 3 |
147 | pleothropic | 1 |
148 | post-mus | 2 |
149 | post-oida | 1 |
150 | post-r0 | 2 |
151 | post-transurethral | 2 |
152 | pre-oida | 1 |
153 | primary-site | 2 |
154 | proof-of-target | 1 |
155 | prostate/transurethral | 1 |
156 | quadrangle | 4 |
157 | quadrangular | 19 |
158 | r-0 | 1 |
159 | r0 | 228 |
160 | r0/marginal | 1 |
161 | r0/r1 | 5 |
162 | r1/2 | 2 |
163 | random-model | 1 |
164 | rt-dose | 1 |
165 | same-session | 3 |
166 | sanitat | 1 |
167 | sub-perichondrial | 1 |
168 | suicidal/homicidal | 1 |
169 | suppressive | 537 |
170 | supra-auricular | 1 |
171 | thransthoracic | 1 |
172 | thrombolysable | 1 |
173 | time-of-sample | 1 |
174 | trait-specific | 7 |
175 | trans-cervical | 1 |
176 | transuretheral | 3 |
177 | trapezial | 8 |
178 | uncertain/negative | 4 |
179 | upregulatory | 1 |
180 | wedge/tumor | 1 |
181 | whole-gland | 5 |
182 | whole-tumor | 1 |
1 | erα+ | 1 |
2 | r-0 | 1 |
3 | r0 | 228 |
4 | post-r0 | 2 |
5 | crm/r0 | 1 |
6 | 37.191 | 1 |
7 | r0/r1 | 5 |
8 | hdc/il-2 | 5 |
9 | r1/2 | 2 |
10 | 70,154 | 1 |
11 | 5,436 | 1 |
12 | 29,697 | 2 |
13 | a-2a | 1 |
14 | pre-oida | 1 |
15 | post-oida | 1 |
16 | graft-vs-leukaemia | 1 |
17 | discontinua | 1 |
18 | anti-bc | 1 |
19 | thransthoracic | 1 |
20 | non-transthoracic | 1 |
21 | trait-specific | 7 |
22 | acupoint-specific | 1 |
23 | anti-metabolic | 1 |
24 | mesocolic | 7 |
25 | ergogenic | 166 |
26 | leukemogenic | 6 |
27 | arythmogenic | 1 |
28 | antileukopenic | 1 |
29 | ileocolonic | 26 |
30 | biopsy/hysteroscopic | 1 |
31 | pleothropic | 1 |
32 | ionophoric | 1 |
33 | nonanesthetic | 7 |
34 | non-hematopoietic | 5 |
35 | antiadrenergic/vagomimetic | 1 |
36 | anti-fibrogenetic | 1 |
37 | anticirrhotic | 1 |
38 | estrogen-agonistic | 2 |
39 | estrogen-antagonistic | 1 |
40 | chemoacoustic | 1 |
41 | antiluteolytic | 1 |
42 | gonadotoxic | 13 |
43 | bloc | 101 |
44 | evidence-guided | 3 |
45 | empirically-based | 5 |
46 | etoricoxib-related | 1 |
47 | 'blue-light'-assisted | 1 |
48 | ayahuasca-assisted | 1 |
49 | mini-fluorescence-assisted | 1 |
50 | embolization-assisted | 1 |
51 | whole-gland | 5 |
52 | apicectomy/root-end | 1 |
53 | nonsecond | 1 |
54 | medium-large | 9 |
55 | moderate-to-large | 18 |
56 | medium-to-large | 21 |
57 | alarge | 1 |
58 | aldosterone-like | 1 |
59 | ischemia-reperfusion-like | 2 |
60 | gibbs-like | 1 |
61 | thrombolysable | 1 |
62 | mineralizable | 2 |
63 | quadrangle | 4 |
64 | antiwrinkle | 3 |
65 | time-of-sample | 1 |
66 | anthracycline-cytarabine | 1 |
67 | dual-shape | 1 |
68 | rt-dose | 1 |
69 | azt-monophosphate | 1 |
70 | primary-site | 2 |
71 | firstcyte | 2 |
72 | discohesive | 3 |
73 | suppressive | 537 |
74 | immune-suppressive | 6 |
75 | eradicative | 2 |
76 | uncertain/negative | 4 |
77 | interrogative | 9 |
78 | alleviative | 1 |
79 | immunomodulative | 6 |
80 | curative | 1,995 |
81 | 'curative | 6 |
82 | noncurative | 13 |
83 | biopreservative | 5 |
84 | mi-protective | 1 |
85 | immunoprotective | 20 |
86 | additive | 1,848 |
87 | atropine-sensitive | 2 |
88 | antinocicepitve | 1 |
89 | cell-reducing | 1 |
90 | astigmatism-reducing | 4 |
91 | obesity-reducing | 1 |
92 | anti-feeding | 8 |
93 | down-staging | 13 |
94 | metabolism/signaling | 1 |
95 | antiremodeling | 9 |
96 | intestine-conditioning | 1 |
97 | concentrate-sparing | 2 |
98 | ics-sparing | 2 |
99 | mcp-1-lowering | 1 |
100 | c-lowering | 1 |
101 | event-lowering | 1 |
102 | inflammation-attenuating | 1 |
103 | aromatase-inhibiting | 1 |
104 | outcome-limiting | 1 |
105 | life-saving | 207 |
106 | antirefluxing | 6 |
107 | group-by-week | 1 |
108 | electrosurgical | 198 |
109 | trans-cervical | 1 |
110 | perfusion+local | 1 |
111 | suicidal/homicidal | 1 |
112 | piecemeal | 23 |
113 | abdominoperineal | 73 |
114 | extra-beneficial | 1 |
115 | sub-perichondrial | 1 |
116 | 'circumferential | 1 |
117 | marsupialization/partial | 2 |
118 | trapezial | 8 |
119 | r0/marginal | 1 |
120 | transuretheral | 3 |
121 | post-transurethral | 2 |
122 | prostate/transurethral | 1 |
123 | mesorectal | 200 |
124 | gross-total | 10 |
125 | random-model | 1 |
126 | anti-all | 1 |
127 | kirkendall | 2 |
128 | moderate-to-small | 1 |
129 | fm-to-am | 3 |
130 | alprazolam/zolpidem | 2 |
131 | osteopenia-an | 1 |
132 | agency/european | 1 |
133 | estrogenic/anti-estrogen | 1 |
134 | knock-on | 4 |
135 | anti-parkinsonion | 1 |
136 | antiaggression | 2 |
137 | same-session | 3 |
138 | antiperoxidation | 1 |
139 | ivf-preimplantation | 1 |
140 | placebo-plus-interaction | 3 |
141 | antireflection | 1 |
142 | human-function | 1 |
143 | 'electron | 1 |
144 | modo | 1 |
145 | belly-strip | 1 |
146 | contour-loop | 2 |
147 | cvrp | 4 |
148 | hangar | 1 |
149 | supra-auricular | 1 |
150 | quadrangular | 19 |
151 | bystander | 140 |
152 | de-copper | 2 |
153 | low-anterior | 1 |
154 | medio-posterior | 1 |
155 | whole-tumor | 1 |
156 | graft-versus-tumor | 6 |
157 | wedge/tumor | 1 |
158 | high/poor | 1 |
159 | inmuno-supressor | 1 |
160 | anti-tumorigenesis | 1 |
161 | hourglass | 9 |
162 | post-mus | 2 |
163 | multitudinous | 3 |
164 | anti-anginous | 1 |
165 | sanitat | 1 |
166 | anticonflict | 1 |
167 | proof-of-target | 1 |
168 | acl-remnant | 2 |
169 | 2013.anticonvulsant | 1 |
170 | myo-relaxant | 1 |
171 | ar-dependent | 2 |
172 | p-treatment | 1 |
173 | a-2b/rbv | 4 |
174 | anti-cinv | 2 |
175 | old/new | 24 |
176 | first-ray | 9 |
177 | h01-emergency | 2 |
178 | 'id-verify | 1 |
179 | magnetic-memory | 1 |
180 | upregulatory | 1 |
181 | photoinhibitory | 3 |
182 | kuntz | 1 |